The Glacial® Rx Story
Headquartered in Silicon Valley, R2 Technologies is the world leader in CryoAesthetics™ medical devices. Our Glacial® platform for precision contact cooling of the skin has been shown to reduce inflammation and also brighten dark spots.
In 2014, Pansend LLC, the life sciences segment of INNOVATE (NYSE: VATE), founded R2 together with Blossom Innovations, LLC and Massachusetts General Hospital to develop a technology based on their patented method of CryomodulationTM. In 2019, R2 brought on a strategic partner, Huadong Medicine Co., Ltd.
Since that time, R2 has conducted the design, development and extensive clinical research to bring Glacial® Rx and Glacial®Spa to market along with an exciting product pipeline.
Our scientific founders and world-famous luminaries in aesthetic medicine, focus on the development, engineering, clinical research, and commercialization of groundbreaking technologies for aesthetic providers and consumers.
Our highly experienced and passionate leadership team works to bring Glacial® Rx to practices around the world so patients can experience the Glacial difference: better skin from within.
Board of Directors
Founded in 2016 by Nicolas Travis, a Forbes “30 Under 30,” and sold in more than 29 markets worldwide and counting, cult-favorite brand Allies of Skin creates multi-benefit formulas for all skin types that work harder and smarter.
Huadong Medicine Co., Ltd., is a leading Chinese pharmaceutical company based in Hangzhou, China. Huadong Medicine possesses one of the most extensive commercial coverage and marketing capabilities in China.
Fraxel is a registered trademark of Solta and CoolSculpting is a registered trademark of Allergan.